References
- Kasteel EEJ, Westerink RHS. Refining in vitro and in silico neurotoxicity approaches by accounting for interspecies and interindividual differences in toxicodynamics. Expert Opin Drug Metab Toxicol. 2021 Feb 14: 1–11. DOI:10.1080/17425255.2021.1885647.
- Burnett SD, Blanchette AD, Chiu WA, et al. Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization. Expert Opin Drug Metab Toxicol. 2021 Mar 8: 1–16. DOI:10.1080/17425255.2021.1894122.
- Supadmanaba IGP, Comandatore A, Morelli L, et al. Organotypic-liver slide culture systems to explore the role of extracellular vesicles in pancreatic cancer metastatic behavior and guide new therapeutic approaches. Expert Opin Drug Metab Toxicol. 2021 May 21: 1–10. DOI:10.1080/17425255.2021.1925646.
- Tcheremenskaia O, Benigni R. Towards regulatory acceptance and improving the prediction confidence of in silico approaches: a case study of genotoxicity. Expert Opin Drug Metab Toxicol. 2021 Jun 3: 1–19. DOI:10.1080/17425255.2021.1938540.
- Breen M, Ring CL, Kreutz A, et al. High-throughput PBTK models for in vitro to in vivo extrapolation. Expert Opin Drug Metab Toxicol. 2021 May 31: 1–19. DOI:10.1080/17425255.2021.1935867.
- Liang X, Lai Y. Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance. Expert Opin Drug Metab Toxicol. 2021 Apr 1: 1–18. DOI:10.1080/17425255.2021.1912012.
- Sung JH. Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs. Expert Opin Drug Metab Toxicol. 2021 Apr 5: 1–18. DOI:10.1080/17425255.2021.1908996.
- Mapanao AK, Che PP, Sarogni P, et al. Tumor grafted - chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation. Expert Opin Drug Metab Toxicol. 2021 Feb 10: 1–22. DOI:10.1080/17425255.2021.1879047.
- Tukker AM, Westerink RHS. Novel test strategies for in vitro seizure liability assessment. Expert Opin Drug Metab Toxicol. 2021 Feb 17: 1–14. DOI:10.1080/17425255.2021.1876026.